-
Boehringer Ingelheim Jascayd receives regulatory approval for progressive pulmonary fibrosis in China
11 Dec 2025 10:52 GMT
Ingelheim: Boehringer Ingelheim has announced that China' … Head of Human Pharma at Boehringer Ingelheim. “While this initial approval in …
-
<![CDATA[Dr Jänne on Selecting a Combination Regimen in First-Line EGFR+ NSCLC]]>
12 Dec 2025 23:12 GMT
… committee for AstraZeneca, Mirati Therapeutics, Boehringer Ingelheim, Plizer, Roche/Genentech, Chugai … grants or contracts from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Takeda, PUMA, Astellas …
-
Federal Circuit Overturns $39M Jury Verdict, Reinforcing Strict Written Description Requirements for Genus Claims
12 Dec 2025 23:57 GMT
… evidence.” Id. at *3 (quoting Boehringer Ingelheim Vetmedica, Inc. v. Scherlng-Plough …
-
i3 Announces Three Deals At 3rd Access To Markets Event
12 Dec 2025 18:11 GMT
… .”
The third announcement came from Boehringer Ingelheim’s Social Engagement Fund, which … Health, HELP Logistics, Sanofi, and Boehringer Ingelheim, i3 says A2M continues to …
-
Finerenone reduces albuminuria in adults with type 1 diabetes
12 Dec 2025 15:57 GMT
… for Alexion, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Dimerix, Eli Lilly, Novartis, Novo … research support from AstraZeneca, Bayer, Boehringer Ingelheim, Novo Nordisk and travel support …
-
Manage obesity with evidence-based solutions
12 Dec 2025 15:57 GMT
… reports consulting for Amgen, Bayer, Boehringer Ingelheim, Eli Lilly, Jazz, Medtronic, Novartis … steering committee member for Arrowhead, Boehringer Ingelheim, Cleerly Health, Medtronic, Novartis and …
-
Nimacimab plus semaglutide safe, confers significant weight loss
12 Dec 2025 15:57 GMT
… reports advising for Altimmune, Atria, Boehringer Ingelheim, CinFina Pharma, Corteria, Eli Lilly …
-
Daily Multivitamins Quietly Lower Blood Pressure in Some Older Adults
12 Dec 2025 14:56 GMT
… Squibb, Inari, Daiichi Sankyo and Boehringer Ingelheim, all unrelated to this study.
-
China Approves First New Progressive Pulmonary Fibrosis Drug in 5 Years
12 Dec 2025 12:50 GMT
… with the condition,” she said.
Boehringer Ingelheim, the company behind JASCAYD, described …
-
Baseline Heart Rate Variability & Age Predict taVNS Response
12 Dec 2025 12:04 GMT
… , Otsuka Pharma GmbH, UCB, Janssen, Boehringer Ingelheim, and Cyclerion.
This article was …